Low serum magnesium concentrations are associated with a high prevalence of premature ventricular complexes in obese adults with type 2 diabetes

Cardiovascular Diabetology

Volumn 11, Issue , 2012, Pages

  Del Gobbo, Liana C ^a   Song, Yiqing ^b   Poirier, Paul ^c   Dewailly, Eric ^d   Elin, Ronald J ^e   Egeland, Grace M ^a  

^a MCGILL UNIVERSITY   (Canada)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c LAVAL UNIVERSITY   (Canada)

^d LAVAL UNIVERSITY   (Canada)

^e University of Louisville School of Medicine   (United States)

Author keywords

Arrhythmia; Ectopic beats; Hypomagnesemia; Magnesium; Premature ventricular beats; Premature ventricular complexes; Type 2 diabetes

Indexed keywords

ANTIHYPERTENSIVE AGENT; DOCOSAHEXAENOIC ACID; HYPOCHOLESTEROLEMIC AGENT; ICOSAPENTAENOIC ACID; MAGNESIUM;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EXERCISE; FEMALE; HEALTH SURVEY; HEART RATE VARIABILITY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HOLTER MONITORING; HUMAN; HYPERTENSION; HYPOMAGNESEMIA; KIDNEY DISEASE; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PREVALENCE; SMOKING; BLOOD; CANADA; COMORBIDITY; HEART RATE; MIDDLE AGED; STATISTICAL MODEL;

ADULT; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH SURVEYS; HEART RATE; HUMANS; LOGISTIC MODELS; MAGNESIUM; MALE; MIDDLE AGED; OBESITY; PREVALENCE; QUEBEC; VENTRICULAR PREMATURE COMPLEXES;

EID: 84862806060     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-11-23     Document Type: Article

References (42)

1. Kennedy HL, Whitlock JA, Sprague MK, Kennedy LJ, Buckingham TA, Goldberg RJ. Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med 1985, 312:193-197. 10.1056/NEJM198501243120401, 2578212.
2. Gaita F, Giustetto C, Di Donna P, Richiardi E, Libero L, Rosa MC, Molinari G, Trevi G. Long-term follow-up of right ventricular monomorphic extrasystoles. J Am Coll Cardiol 2001, 38:364-370. 10.1016/S0735-1097(01)01403-6, 11499725.
3. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Frederiksen BS, Davanlou M, Hansen JF. Ventricular arrhythmias and risk of death and acute myocardial infarction in apparently healthy subjects of age > = 55 years. Am J Cardiol 2006, 97:1351-1357. 10.1016/j.amjcard.2005.11.067, 16635610.
4. Cheriyath P, He F, Peters I, Li XA, Alagona P, Wu CT, Pu M, Cascio WE, Liao DP. Relation of atrial and/or ventricular premature complexes on a two-minute rhythm strip to the risk of sudden cardiac death (the atherosclerosis risk in communities [ARIC] study. Am J Cardiol 2011, 107:151-155. 10.1016/j.amjcard.2010.09.002, 21211594.
5. Stein PK, Sanghavi D, Sotoodehnia N, Siscovick DS, Gottdiener J. Association of Holter-based measures including T-wave altemans with risk of sudden cardiac death in the community-dwelling elderly: the cardiovascular health study. J Electrocardiol 2010, 43:251-259. 10.1016/j.jelectrocard.2009.12.009, 2856790, 20096853.
6. Abdalla ISH, Prineas RJ, Neaton JD, Jacobs DR, Crow RS. Relation between ventricular premature complexes and sudden cardiac death in apparently healthy men. Am J Cardiol 1987, 60:1036-1042. 10.1016/0002-9149(87)90348-1, 3673904.
7. Raiha IJ, Piha SJ, Seppanen A, Puukka P, Sourander L. Predictive value of continuous ambulatory electrocardiographic monitoring in elderly people. Br Med J 1994, 309:1263-1267.
8. Fawcett WJ, Haxby EJ, Male DA. Magnesium: physiology and pharmacology. Br J Anaesth 1999, 83:302-320.
9. Abbot LG, Rude RK. Clinical manifestations of magnesium deficiency. Miner Electrolyte Metab 1993, 19:314-322.
10. Parikka H, Toivonen L, Naukkarinen V, Tierala I, Pohjola-Sintonen S, Heikkila J, Nieminen MS. Decreases by magnesium of QT dispersion and ventricular arrhythmias in patients with acute myocardial infarction. Eur Heart J 1999, 20:111-120. 10.1053/euhj.1998.1238, 10099907.
11. Chakraborti S, Chakraborti T, Mandal M, Mandal A, Das S, Ghosh S. Protective role of magnesium in cardiovascular diseases: a review. Mol Cell Biochem 2002, 238:163-179. 10.1023/A:1019998702946, 12349904.
12. Nielsen FH, Milne DB, Klevay LM, Gallagher S, Johnson L. Dietary magnesium deficiency induces heart rhythm changes, impairs glucose tolerance, and decreases serum cholesterol in post menopausal women. J Am Coll Nutr 2007, 26:121-132.
13. Klevay LM, Milne DB. Low dietary magnesium increases supraventricular ectopy. Am J Clin Nutr 2002, 75:550-554.
14. Tsuji H, Venditti FJ, Evans JC, Larson MG, Levy D. The associations of levels of serum potassium and magnesium with ventricular premature complexes (The Framingham heart study). Am J Cardiol 1994, 74:232-235. 10.1016/0002-9149(94)90362-X, 7518645.
15. Rude RK, Shils ME. Magnesium. Modern Nutrition in Health and Disease 2006, 234. New York: Lippincott Williams & Wilkins, Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ, 10.
16. Escobedo LG, Caspersen CJ. Risk factors for sudden coronary death in the United States. Epidemiol 1997, 8:175-180.
17. Nituuchischaayihtitaau Aschii Multi-community Environment-and-health. Longitudinal Study in Iiyiyiu Aschii: Mistissini technical report: summary of activities, results and recommendations. , http://www.creehealth.org/sites/default/files/Environmental%20Health%20Study-%20Technical%20Report%20of%20Mistissini.pdf
18. Harris SB, Gittelsohn J, Hanley A, Barnie A, Wolever TM, Gao XJ, Logan A, Zinman B. The prevalence of NIDDM and associated risk factors in native Canadians. Diabetes Care 1997, 20:185-187. 10.2337/diacare.20.2.185, 9118771.
19. Egeland GM, Denomme D, Lejeune P, Pereg D. Concurrent validity of the international physical activity questionnaire (IPAQ) in an Iiyiyiu Aschii (Cree) community. Can J Pub Health 2008, 99:307-310.
20. Russo GL. Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. Biochem Pharmacol 2009, 77:937-946. 10.1016/j.bcp.2008.10.020, 19022225.
21. Mozaffarian D, Psaty BM, Rimm EB, Lemaitre RN, Burke GL, Lyles MF, Lefkowitz D, Siscovick DS. Fish intake and risk of incident atrial fibrillation. Circulation 2004, 110:368-373. 10.1161/01.CIR.0000138154.00779.A5, 1201400, 15262826.
22. Alberti KGMM, Ecklel RH, Grundy SM, . IDF Epidemiology Task Force Consensus Group Harmonizing the metabolic syndrome. Circulation 2009, 120:1640-1645. 10.1161/CIRCULATIONAHA.109.192644, 19805654, IDF Epidemiology Task Force Consensus Group.
23. Stein PK, Barzilay JI, Chaves PHM, Mistretta SQ, Domitrovich PP, Gottdiener JS, Rich MW, Kleiger RE. Novel measures of heart rate variability predict cardiovascular mortality in older adults independent of traditional cardiovascular risk factors: the cardiovascular health study (CHS). J Cardio Electrophysiol 2008, 19:1169-1174.
24. Alghamdi SMG, Cameron EC, Sutton RAL. Magnesium deficiency: pathophysiologic and clinical overview. Am J Kidney Dis 1994, 24:737-752.
25. Loeb HS, Pietras RJ, Gunnar RM, Tobin JR. Paroxysmal ventricular fibrillation in two patients with hypomagnesemia. Circulation 1968, 3:210-215.
26. Dyckner T, Wester PO. Magnesium deficiency contributing to ventricular tachycardia. Acta Med Scand 1982, 212:89-91.
27. Ramme SP, White CJ, Svinarich JT, Watson TD, Fox RF. Torsade de pointes and magnesium deficiency. Am Heart J 1985, 109:89-91.
28. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of cardiology/American heart association task force and the European Society of cardiology committee for practice guidelines (Writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death). J Am Coll Cardiol 2006, 48:e247-e346. 10.1016/j.jacc.2006.07.010, 16949478.
29. Belardinelli L, Antzelevitch C, Vos MA. Assessing predictors of drug-induced torsade de pointes. Trends Pharmacol Sci 2003, 24:619-625. 10.1016/j.tips.2003.10.002, 14654302.
30. Millante TA, Ward DE, Camm AJ. Is hypomagnesemia arrhythmogenic?. Clin Cardiol 1992, 15:103-108. 10.1002/clc.4960150210, 1371093.
31. Mubagwa K, Gwanyanya A, Zakharov S, Macianskiene R. Regulation of cation channels in cardiac and smooth muscle cells by intracellular magnesium. Arch Biochem Biophys 2007, 458:73-89. 10.1016/j.abb.2006.10.014, 17123458.
32. Harris I, Levin D. The effects upon the human electrocardiogram of the introduction of calcium and potassium into the blood. J Physiol 1937, 89:153. 1395017, 16994852.
33. Saran T, Perkins JD, Javed MA. Does the prophylactic administration of magnesium sulphate to patients undergoing thoracotomy prevent postoperative supraventricular arrhythmias? A randomized controlled trial. Br J Anaesth 2011, 106:785-791. 10.1093/bja/aer096, 21558066.
34. Håglin L, Backman L, Tornkvist BL. A structural equation model for assessment of links between changes in serum triglycerides, -urate, and -glucose and changes in serum calcium, -magnesium and -phosphate in type 2 diabetes and non-diabetes metabolism. Cardiovasc Diabetol 2011, 10:116. 10.1186/1475-2840-10-116, 3265426, 22192330.
35. Simmons D, Joshi S, Shaw J. Hypomagnesaemia is associated with diabetes: not pre-diabetes, obesity or the metabolic syndrome. Diabetes Res Clin Pract 2010, 87:261-266. 10.1016/j.diabres.2009.11.003, 20004036.
36. Røislien J, Van Calster B, Hjelmesæth J. Parathyroid hormone is a plausible mediator for the metabolic syndrome in the morbidly obese: a cross-sectional study. Cardiovasc Diabetol 2011, 10:17. 10.1186/1475-2840-10-17, 3042378, 21306649.
37. Kalaitzidis R, Tismihodimos V, Bairaktari E, Siamopoulos K, Elisaf M. Disturbances of phosphate metabolism: another feature of the metabolic syndrome. J Kidney Dis 2005, 45:851-858.
38. de Valk HW. Magnesium in diabetes mellitus. Neth J Med 1999, 54:139-146. 10.1016/S0300-2977(99)00005-4, 10218382.
39. Peacock JM, Ohira T, Post W, Sotoodehnia N, Rosamond W, Folson AR. Serum magnesium and risk of sudden cardiac death in the atherosclerosis risk in communities (aric) study. Am Heart J 2010, 160:464-470. 10.1016/j.ahj.2010.06.012, 2939007, 20826254.
40. Reffelmann T, Ittermann T, Dörr M, Völzke H, Reinthaler M, Petersmann A, Felix SB. Low serum magnesium concentrations predict cardiovascular and all-cause mortality. Atherosclerosis 2011, 219:280-284. 10.1016/j.atherosclerosis.2011.05.038, 21703623.
41. Ford ES. Serum magnesium and ischaemic heart disease: findings from a national sample of US adults. Int J Epidemiol 1999, 28:645-651. 10.1093/ije/28.4.645, 10480691.
42. Barbagallo M, Dominguez LJ. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys 2007, 458:40-47. 10.1016/j.abb.2006.05.007, 16808892.